Author(s): Wafaa Sh. Al - Zuhairi, Ekhlas Abdallah Hassan, Alzahraa Ibrahim Abdulmajeed

Email(s): wafaa.chem@gmail.com , ekhlasbiochemistry@gmail.com , Zahraa1987.zo@gmail.com

DOI: 10.52711/0974-360X.2022.00346   

Address: Wafaa Sh. Al - Zuhairi, Ekhlas Abdallah Hassan, Alzahraa Ibrahim Abdulmajeed
Department of Chemistry, College of Science, University of Diyala, Baquba, Diyala, Iraq.
*Corresponding Author

Published In:   Volume - 15,      Issue - 5,     Year - 2022


ABSTRACT:
The goal of this study is to determine the concentration of total zinc, iron, ESR, PCV, Hb, CBC in the serum of patients with polycythemia vera. These results are indicated that age of patient and control group Iraq males are to some extend similar. Whereas, average value of ESR ±SD for patient and control groups were (8.36± 4.41) and (15.40± 5.10), respectively. It was clearly indicated that ESR for patient higher than control group. The erythrocyte sedimentation rate (ESR) is decreased due to an increase in zeta potential. While, the average iron ±SD for patient and control group were (35.12 ± 8.21) and (23.48 ± 2.40) respectively. The level of zinc shows no significant difference between polycythemic and control gropes. Also show that there was a highly significance in packed cell volume between patient groups (51.49±4.62) when compared with control groups (36.30±3.22). The mean ±SD of Hb and WBC for patient and control group were (16.08 ± 1.14) (12.40 ± 0.68) and (12.04 ± 3.17) (8.21 ± 1.48) respectively. These results are showed that Hb, WBC of patient strongly higher compering to control group (p>0.05). the majority of patients were at the age between (41-50) years with percentage of (30.76%), (31-40) years with a percentage (25.64%) and (20-30) years with a percentage (23.07%). While age groups between (51-60) years were (12.82%) and age groups (>60) years were (7.7%). The result show that (2.5) percent of patients had PCV level less than normal, (38.5) percent of patients had normal level and (59) percent of patients showed concentration more than normal as shown in (Table 4). There are (5.1) percent of patients showed level less than normal, (53.8) percent of patients had normal level and (41) percent of patients showed concentration more than normal. The current study has been shown that the concentration of biochemical parameters is influenced by polycythemia.


Cite this article:
Wafaa Sh. Al - Zuhairi, Ekhlas Abdallah Hassan, Alzahraa Ibrahim Abdulmajeed. Status of Zinc, Iron and some Biochemical Parameters in patients with Polycythemia. Research Journal of Pharmacy and Technology. 2022; 15(5):2093-6. doi: 10.52711/0974-360X.2022.00346

Cite(Electronic):
Wafaa Sh. Al - Zuhairi, Ekhlas Abdallah Hassan, Alzahraa Ibrahim Abdulmajeed. Status of Zinc, Iron and some Biochemical Parameters in patients with Polycythemia. Research Journal of Pharmacy and Technology. 2022; 15(5):2093-6. doi: 10.52711/0974-360X.2022.00346   Available on: https://rjptonline.org/AbstractView.aspx?PID=2022-15-5-28


REFERENCES:
1.    Maran J., J. Pichal., Pathol. Biol.(Paris),( 2004), 52, 280.
2.    Ramnik S. Textbook of Medical Laboratory Technology, New Delhi, Jaypee Brothers Medical Publishers(P) Ltd, (2006) 1st edition, 203.
3.    Streiff MB, Smith B, Spivak JL. "The diagnosis and management of polycythemia vera in the era since the Polycythemia Vera Study Group: a survey of American Society of Hematology members' practice patterns". (2002): Blood 99 (4): 1144–9. doi:10.1182/blood.V99.4.1144. PMID 11830459.
4.    Scott LM, Scott MA, Campbell PJ, Green AR.. Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia. (2006).  Blood;108:2435-7. doi: 10.1182/blood-2006-04-018259.
5.    Campbell PJ, Scott LM, Buck G, Wheatley K, East CL, Marsden JT, et al. Definition of subtypes of essential thrombocythemia and relation to polycythemia vera based on JAK2 V617F mutation status: a prospective study. United Kingdom Myeloproliferative Disorders Study Group; Medical Research Council Adult Leukaemia Working Party; Australasian Leukaemia and Lymphoma Group. .( 2005). Lancet;366:1945-53. doi: 10.1016/S0140-6736(05)67785-9.
6.    Ma X1, Vanasse G, Cartmel B, Wang Y, Selinger HA. "Prevalence of polycythemia vera and essential thrombocythemia". (2008).  Am J Hematol. 2008 May;83(5):359-62. doi: 10.1002/ajh.21129.
7.    Siebolts U, Breuhahn K, Hennecke A, Schultze JL, Wickenhauser C. "Imbalance of DNA-dependent protein kinase subunits in polycythemia vera peripheral blood stem cells". (2009). Int J Cancer. Feb 1;124(3):600-7.  doi: 10.1002/ijc.23985
8.    Lippert E, Boissinot M, Kralovics R, Girodon F, Dobo I, Praloran V, et al. " The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera". (2006). Blood;108:1865. doi: 10.1182/blood-2006-01-013540.
9.    Saini K.S., M.M. Patnaik, A. Tefferi. (2010). Eur. J. Clin. Invest., 40(9), 828.
10.    Fjeliner B., O. Hagermark., Acta. Derm. Venereol. (1979), 59(6), 505.
11.    Steinman H., A. Kobza-Black, T. Lotti, L. Brunetti, E. Panconesi, M. Greaves.(1987). Br. J Dermatol. 116(3), 329.
12.    Torgano. G., C. Mandeli, P. Massaro, C. Abbati, A. Ponzetto, G. Bertinieri, S. Bogetto, E. Terruzzi, A. de Franchis. (2002). Br. J. Haematol , 117(1), 198.
13.    Wafaa Sh. Al-Zuhairi .” Evaluation Zinc, Copper and Iron Concentrations in Children with Beta Thalassemia Major in Diyala Province”. (2017). Diyala Journal for Pure Science.  Vol: 13 No:4.
14.    Okpokam DC, Emeribe AO, Akpotuzor JO.” Frequency of blood donation and iron stores of blood donors in calabar, Cross River, Nigeria”. (2012). International Journal of Biomedical Laboratory Science (IJBLS). 2: 40-43.
15.    Ahsan K. Abbas, Mohammed S. Al-Sayab,  Mayssa J. Majeed. Status of Some Minerals in Patients with Polycythemia using Colorimetric Method. (2010). Journal of Faculty of Medicine Baghdad. Vol. 52, No.1. DOI: https://doi.org/10.32007/jfacmedbagdad.5211068
16.    McGraw Hill Lange.Current Medical Diagnosis & Treatment. .(2008). p. 438.
17.    Carole Sanchez , Thérèse Le Treut , Céline Baier , Gérard Sébahoun , Régis T Costello . “Distribution of lymphocyte subpopulations in patients with polycythemia vera”. (2015).  Human Immunology. issue 6 , vol 76. doi: 10.1016/j.humimm.2015.03.021.
18.    Akinjide M. Akinnuga, Olubayode Bamidele and Ijeoma C. Chukwuebuka. Correlation between Packed Cell Volume and Body Mass Index in Hypertensive and Normotensive Subjects. (2011). (2):65-71. (http://scholarsresearchlibrary.com/archive.html)
19.    Gilbert, HS. Modern treatment strategies in polycythemia vera. (2003). Semin Hematol. Jan;40(1 Suppl 1):26-9.
20.    Barbui T, Carobbio A, Rambaldi A, Finazzi G. Perspectives on thrombosis in essential thrombocythemia and polycythemia vera: is leukocytosis a causative factor. (2009). Blood ;1144: 759–63.
21.    Pearson TC, Messinezy M, Westwood N, et al. “Hematology ,Am Soc Hem11- Polycythemia Vera Updated: Diagnosis, Pathobiology, and Treatment.” (2000). atol Educ Program :51-68.
22.    Ang SO, Chen H, Hirota K, et al. "Disruption of Oxygen homeostasis underlies congenital Chuvash polycythemia".  (December 2002). Nat.Genet. 32 (4): 614–21. doi:10.1038/ng1019. PMID 12415268.
23.    Passamonti F, Malabarba L, Orlandi E, Baratè C, Canevari A.” Polycythemia vera in young patients: a study on the long-term risk of thrombosis, myelofibrosis and leukemia.” (2003). Vol. 88 No. 1.

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

0.38
2018CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available